• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向阿片受体治疗成瘾和戒断:我们的路在何方?

Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?

机构信息

Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.

出版信息

Int J Mol Sci. 2023 Jun 29;24(13):10888. doi: 10.3390/ijms241310888.

DOI:10.3390/ijms241310888
PMID:37446064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341731/
Abstract

This review article offers an outlook on the use of opioids as therapeutics for treating several diseases, including cancer and non-cancer pain, and focuses the analysis on the opportunity to target opioid receptors for treating opioid use disorder (OUD), drug withdrawal, and addiction. Unfortunately, as has been well established, the use of opioids presents a plethora of side effects, such as tolerance and physical and physiological dependence. Accordingly, considering the great pharmacological potential in targeting opioid receptors, the identification of opioid receptor ligands devoid of most of the adverse effects exhibited by current therapeutic agents is highly necessary. To this end, herein, we analyze some interesting molecules that could potentially be useful for treating OUD, with an in-depth analysis regarding in vivo studies and clinical trials.

摘要

这篇综述文章展望了阿片类药物作为治疗多种疾病(包括癌症和非癌症疼痛)的治疗方法的应用,并重点分析了针对阿片受体治疗阿片类药物使用障碍(OUD)、药物戒断和成瘾的机会。不幸的是,正如已经充分确立的那样,阿片类药物的使用存在诸多副作用,如耐受和身体及生理依赖。因此,考虑到靶向阿片受体具有巨大的药理学潜力,识别出大多数当前治疗药物所表现出的不良反应的阿片受体配体是非常必要的。为此,本文分析了一些可能对治疗 OUD 有用的有趣分子,并对体内研究和临床试验进行了深入分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/10341731/6b40e5d6170a/ijms-24-10888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/10341731/6b40e5d6170a/ijms-24-10888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/10341731/6b40e5d6170a/ijms-24-10888-g001.jpg

相似文献

1
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?靶向阿片受体治疗成瘾和戒断:我们的路在何方?
Int J Mol Sci. 2023 Jun 29;24(13):10888. doi: 10.3390/ijms241310888.
2
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.阿片类药物戒断症状是慢性阿片类药物使用和阿片类药物使用障碍的后果:目前的认识和管理方法。
J Clin Pharm Ther. 2020 Oct;45(5):892-903. doi: 10.1111/jcpt.13114. Epub 2020 Jan 27.
3
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.医院环境中阿片类药物戒断的管理和阿片类药物使用障碍药物的启用。
Hosp Pract (1995). 2022 Oct;50(4):251-258. doi: 10.1080/21548331.2022.2102776. Epub 2022 Jul 22.
4
Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.辅助使用非阿片类药物大麻二酚治疗阿片类药物戒断。
Cannabis Cannabinoid Res. 2022 Oct;7(5):569-581. doi: 10.1089/can.2021.0089. Epub 2021 Oct 22.
5
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder.超越阿片受体:对治疗阿片类药物使用障碍的新疗法的迫切需求。
J Neurol Sci. 2022 Jan 15;432:120094. doi: 10.1016/j.jns.2021.120094. Epub 2021 Dec 16.
6
Adjunctive memantine for opioid use disorder treatment: A systematic review.辅助美金刚治疗阿片类药物使用障碍:系统评价。
J Subst Abuse Treat. 2019 Dec;107:38-43. doi: 10.1016/j.jsat.2019.10.003. Epub 2019 Oct 20.
7
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.细胞对慢性阿片类药物的神经适应性变化:耐受性、戒断反应与成瘾
Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14.
8
The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants.成人未治疗阿片类药物使用障碍中停药对维持阿片类药物成瘾的感知作用:对注射器交换计划参与者的调查。
Subst Use Misuse. 2024;59(2):312-315. doi: 10.1080/10826084.2023.2269571. Epub 2023 Dec 28.
9
Opioid withdrawal: role in addiction and neural mechanisms.阿片类药物戒断:成瘾中的作用和神经机制。
Psychopharmacology (Berl). 2023 Jul;240(7):1417-1433. doi: 10.1007/s00213-023-06370-2. Epub 2023 May 10.
10
The Role of Opioid Receptors in Cancer.阿片受体在癌症中的作用。
Adv Biol (Weinh). 2023 Jul;7(7):e2300102. doi: 10.1002/adbi.202300102. Epub 2023 May 2.

引用本文的文献

1
Molecular Sex Differences and Clinical Gender Efficacy in Opioid Use Disorders: From Pain Management to Addiction.阿片类药物使用障碍中的分子性别差异和临床性别疗效:从疼痛管理到成瘾。
Int J Mol Sci. 2024 Aug 28;25(17):9314. doi: 10.3390/ijms25179314.
2
Substance Addiction Rehabilitation Drugs.物质成瘾康复药物
Pharmaceuticals (Basel). 2024 May 10;17(5):615. doi: 10.3390/ph17050615.
3
Treatment of Moderate-to-Severe Pain in Hepatocellular Carcinoma with Transcutaneous Electrical Acupoint Stimulation: A Randomized Controlled Trial.

本文引用的文献

1
Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans-A Systematic Review and Treatment Guideline.阿片类药物治疗人类慢性特发性腹泻——一项系统评价与治疗指南
J Clin Med. 2023 Mar 24;12(7):2488. doi: 10.3390/jcm12072488.
2
Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder.使用序贯多项分配随机试验来检验应急管理和综合行为经济学与正念干预对阿片类药物使用障碍患者丁丙诺啡-纳洛酮药物依从性的影响。
Trials. 2023 Mar 29;24(1):237. doi: 10.1186/s13063-023-07102-9.
3
经皮穴位电刺激治疗肝细胞癌中重度疼痛:一项随机对照试验
J Pain Res. 2024 Apr 29;17:1583-1594. doi: 10.2147/JPR.S456874. eCollection 2024.
4
Navigating the brain: the role of exosomal shuttles in precision therapeutics.探索大脑:外泌体穿梭载体在精准治疗中的作用
Front Neurol. 2024 Jan 18;14:1324216. doi: 10.3389/fneur.2023.1324216. eCollection 2023.
Oliceridine for the Management of Moderate to Severe Acute Postoperative Pain: A Narrative Review.
奥昔哌啶用于治疗中重度急性术后疼痛的管理:叙事性综述。
Drug Des Devel Ther. 2023 Mar 22;17:875-886. doi: 10.2147/DDDT.S372612. eCollection 2023.
4
Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with Morphine.老年志愿者中偏倚配体奥立沙肽的呼吸效应:与吗啡的药代动力学-药效学比较。
Anesthesiology. 2023 Mar 1;138(3):249-263. doi: 10.1097/ALN.0000000000004473.
5
Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies.大麻和 Δ9-四氢大麻酚缓解阿片类药物戒断:观察性和实验性人体研究的系统评价。
Drug Alcohol Depend. 2022 Dec 1;241:109702. doi: 10.1016/j.drugalcdep.2022.109702. Epub 2022 Nov 18.
6
Structure determination of inactive-state GPCRs with a universal nanobody.利用通用纳米抗体对非活性状态G蛋白偶联受体进行结构测定。
Nat Struct Mol Biol. 2022 Dec;29(12):1188-1195. doi: 10.1038/s41594-022-00859-8. Epub 2022 Nov 17.
7
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.吗啡和芬太尼与人 μ 阿片受体的分子识别。
Cell. 2022 Nov 10;185(23):4361-4375.e19. doi: 10.1016/j.cell.2022.09.041.
8
Endogenous opioid systems alterations in pain and opioid use disorder.疼痛与阿片类物质使用障碍中的内源性阿片系统改变
Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022.
9
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.阿片受体介导的大脑神经传递调节
Front Mol Neurosci. 2022 Jun 15;15:919773. doi: 10.3389/fnmol.2022.919773. eCollection 2022.
10
Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multidisciplinary care.回顾对注射吸毒者侵袭性感染管理重点:强调需要以患者为中心的多学科护理。
Med J Aust. 2022 Jul 18;217(2):102-109. doi: 10.5694/mja2.51623. Epub 2022 Jun 26.